Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ZYDUS LIFESCIENCES AJANTA PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 25.3 22.7 111.8% View Chart
P/BV x 4.8 2.8 169.7% View Chart
Dividend Yield % 0.8 0.5 147.6%  

Financials

 AJANTA PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
AJANTA PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,614674 239.6%   
Low Rs1,089331 328.9%   
Sales per share (Unadj.) Rs391.1149.1 262.3%  
Earnings per share (Unadj.) Rs83.422.7 367.1%  
Cash flow per share (Unadj.) Rs98.129.7 330.4%  
Dividends per share (Unadj.) Rs9.502.50 380.0%  
Avg Dividend yield %0.70.5 141.3%  
Book value per share (Unadj.) Rs382.1166.1 230.1%  
Shares outstanding (eoy) m85.421,023.74 8.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.4 102.6%   
Avg P/E ratio x16.222.1 73.3%  
P/CF ratio (eoy) x13.816.9 81.4%  
Price / Book Value ratio x3.53.0 116.9%  
Dividend payout %11.411.0 103.5%   
Avg Mkt Cap Rs m115,433514,277 22.4%   
No. of employees `000NANA-   
Total wages/salary Rs m6,45821,777 29.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,410152,652 21.9%  
Other income Rs m1,1572,354 49.1%   
Total revenues Rs m34,567155,006 22.3%   
Gross profit Rs m9,29334,427 27.0%  
Depreciation Rs m1,2537,130 17.6%   
Interest Rs m1021,270 8.0%   
Profit before tax Rs m9,09528,381 32.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9685,117 38.5%   
Profit after tax Rs m7,12723,264 30.6%  
Gross profit margin %27.822.6 123.3%  
Effective tax rate %21.618.0 120.0%   
Net profit margin %21.315.2 140.0%  
BALANCE SHEET DATA
Current assets Rs m24,548122,614 20.0%   
Current liabilities Rs m8,37778,394 10.7%   
Net working cap to sales %48.429.0 167.1%  
Current ratio x2.91.6 187.4%  
Inventory Days Days4293 45.1%  
Debtors Days Days1180 13.9%  
Net fixed assets Rs m19,259144,382 13.3%   
Share capital Rs m1721,024 16.8%   
"Free" reserves Rs m32,469168,972 19.2%   
Net worth Rs m32,640169,996 19.2%   
Long term debt Rs m163,621 0.5%   
Total assets Rs m43,807266,996 16.4%  
Interest coverage x90.223.3 386.2%   
Debt to equity ratio x00 2.4%  
Sales to assets ratio x0.80.6 133.4%   
Return on assets %16.59.2 179.6%  
Return on equity %21.813.7 159.5%  
Return on capital %28.217.1 164.9%  
Exports to sales %00-   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA21,869 0.0%   
Fx inflow Rs m18,67863,065 29.6%   
Fx outflow Rs m3,66221,869 16.7%   
Net fx Rs m15,01641,196 36.4%   
CASH FLOW
From Operations Rs m5,62021,041 26.7%  
From Investments Rs m-74111,544 -6.4%  
From Financial Activity Rs m-4,600-8,683 53.0%  
Net Cashflow Rs m27923,729 1.2%  

Share Holding

Indian Promoters % 66.1 75.0 88.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.9 16.2 159.7%  
FIIs % 10.1 2.5 401.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.9 25.0 135.5%  
Shareholders   59,798 370,396 16.1%  
Pledged promoter(s) holding % 19.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on AJANTA PHARMA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Cadila Healthcare Share Price Performance

Period AJANTA PHARMA Cadila Healthcare S&P BSE HEALTHCARE
1-Day 2.72% -1.15% 1.18%
1-Month 3.16% 6.93% -3.20%
1-Year -13.61% 18.25% -7.61%
3-Year CAGR 9.51% 19.34% 16.42%
5-Year CAGR 5.50% 3.20% 9.39%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.1% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 400 Points as RBI Hikes Repo Rate | Adani Group Stocks Rally | Adani Enterprises, Adani Ports Surge Over 6% Sensex Today Gains 400 Points as RBI Hikes Repo Rate | Adani Group Stocks Rally | Adani Enterprises, Adani Ports Surge Over 6%(10:30 am)

Asian share markets rose today after comments from Federal Reserve Chair Jerome Powell boosted risk appetite and investor hoped that the central bank may soon ease monetary policy.